Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G17DT + Chemotherapy in Advanced Gastric/Gastroesophageal Cancer
NCT00020787Phase 3Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jul 2001
- Primary completion
- Jan 2002
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of G17DT immunogen in gastric cancer (GC), esophageal cancer, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jul 2001; status: completed.
02
Drugs
G17DT immunogen
03
Conditions
gastric cancer (GC)esophageal cancer
Beyond the preview
Go deeper on NCT00020787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020787.